Related Experiment Video
Updated: Jun 1, 2026
10:02
Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Triterpenoids with neurotrophic activity from Ganoderma lucidum.
Xiao-Qi Zhang1, Fanny C F Ip, Dong-Mei Zhang
1Institute of Traditional Chinese Medicine and Natural Products, College of Pharmacy, Jinan University, Guangzhou 510632, PR China.
Natural Product Research
|June 15, 2011
Summary
A new triterpenoid from Ganoderma lucidum promotes neuronal survival. This compound and others demonstrated nerve growth factor-like and brain-derived neurotrophic factor-like activities, suggesting potential therapeutic applications.
Area of Science:
- Natural Products Chemistry
- Neuroscience
- Pharmacology
Background:
- Ganoderma lucidum, a medicinal mushroom, is a rich source of bioactive compounds.
- Triterpenoids are a class of compounds known for diverse biological activities.
- Neuronal survival is crucial for brain health and function.
Purpose of the Study:
- To isolate and characterize novel and known triterpenoids from Ganoderma lucidum.
- To investigate the neurotrophic effects of isolated compounds.
- To identify compounds with nerve growth factor (NGF)-like and brain-derived neurotrophic factor (BDNF)-like activities.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation via extensive spectroscopic analyses (NMR, MS).
- Bioassays to assess neuronal survival-promoting effects.
Main Results:
- A new triterpenoid, 4,4,14α-trimethyl-5α-chol-7,9(11)-dien-3-oxo-24-oic acid (1), was identified.
- Compounds 1 and methyl ganoderic acid B (5) exhibited NGF-like neuronal survival effects.
- Compounds 1, and 4-7 displayed BDNF-like neuronal survival activities.
Conclusions:
- The new triterpenoid and known compounds from Ganoderma lucidum possess significant neurotrophic potential.
- These findings highlight Ganoderma lucidum as a valuable source for neuroprotective agents.
- Further research may explore the therapeutic applications of these triterpenoids in neurological disorders.
Related Concept Videos
01:15Antifungal Agents
Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
01:00Enzyme-linked Receptors
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
01:26Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
01:29Drugs Affecting Neurotransmitter Synthesis
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase, which converts...
01:23Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...